![]() |
![]() |
Biological TherapiesThis page contains recent news articles, when available, and an overview of Biological Therapies but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.News: Biological Therapies Today's THVThe patient may be treated with surgery, radiation therapy, chemotherapy, biological therapies and/or complementary and alternative therapies. ... Cytomedix Reports Third Quarter Financial Results - Nov 11, 2009 CNNMoney.com (press release)Cytomedix develops, sells and licenses regenerative biological therapies including the AutoloGel(TM) System, a device for the production of Platelet Rich ... Cytomedix Appoints Dr. Craig Mendelsohn to Board of Directors - Nov 13, 2009 CNNMoney.com (press release)Cytomedix develops, sells and licenses regenerative biological therapies including the AutoloGel(TM) System, a device for the production of Platelet Rich ... REG-Elan Corporation PLC Subset Data from Two Randomized Phase 3 Trials Show ... - Oct 28, 2009 ReutersMany patients fail to respond to current therapies, including biological therapies such as agents that inhibit tumor necrosis factor alpha (TNF-alpha). ... ACR70-disease activity score remission achievement from switches between all ... - Nov 3, 2009 7thSpace Interactive (press release)...a major response (disease activity score (DAS) remission or ACR 70) by switching between all the available biological therapies in rheumatoid arthritis. ... New Report Analyses Possibilities in Drug Delivery to Central Nervous System ... - Nov 10, 2009 PRLog.Org (press release)Furthermore, many of the new developments in the treatment of neurological disorders will be biological therapies and these will require innovative methods ... Comparing notes: UK's cancer leaders discuss the latest advances - Oct 28, 2009 PharmafocusProfessor Cameron pondered whether headline biological therapies such as imatinib (in gastrointestinal stromal tumours) and trastuzumab (in breast cancer) ... Eisai and Quintiles to Jointly Develop Six Eisai Anticancer Agents - Oct 30, 2009 Genetic Engineering News (press release)These included either single agent chemotherapy, hormonal or biological therapies, or palliative treatment/radiotherapy. Preliminary trial results suggested ... More Tysabri Problems; Time for a Biogen-Idec Credibility Check - Oct 30, 2009 BNETBefore criticizing chief executive Jim Mullen & Co., however, the American public needs to remember that all current and emerging biological therapies for ... Providing a Voice to the Millions Who Suffer from the Emotional and Physical ... - Nov 6, 2009 Live-PR.com (Pressemitteilung)For moderate to severe forms of psoriasis, biological therapies that work on the body's immune system are also available and treat the symptoms differently ... Cytomedix Files Application With FDA for autologel(tm) System in ... - 07 Aug 2009 GlobeNewsWire (press release)Cytomedix develops, sells and licenses regenerative biological therapies including the autologel(tm) System, a device for the production of PRP gel derived Rigel Announces Second Quarter 2009 Financial Results - Aug 4, 2009 PR Newswire (press release)...our objective with R788 in rheumatoid arthritis is to position the product after methotrexate and before biological therapies are used. Psoriasis Treatments May Increase Malignancy Risk - Jul 15, 2009 Cancerpage.comThey also consider the cancer risks of the newer biological therapies (alefacept, efalizumab, infliximab, etanercept, adalimumab, and ustekinumab). R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in ... - Jul 23, 2009 PR Newswire (press release)..."Our objective with R788 in RA is to position the product after methotrexate and before biological therapies are used. We have shown excellent results in Small Cap BioPharm Percentage Gainers: SOMX; GTF; AGEN - sourced ... - Aug 3, 2009 TransWorldNews (press release)Maryland, Cytomedix, Inc is a biotechnology company engaged in the development, sale, and licensing of regenerative biological therapies for wound care, Cytomedix Announces Acceptance by NYSE Amex of Plan of Compliance - Jul 29, 2009 GlobeNewsWire (press release)Cytomedix is a biotechnology company that develops, sells and licenses regenerative biological therapies, including the AutoloGel(tm) System, Insurers cut back cover for cancer as treatment costs soar - Jul 14, 2009 Daily MailThe limits have come about because of the rise in what are called 'biological therapies' such as Herceptin or Avastin, which are designed to slow the spread NHS rejects claims of age bias in breast cancer care - Jul 30, 2009 Oxford Mail...and risks associated with all treatments, surgery, chemo-therapy, radiotherapy, hormonal and biological therapies, when making recommendations. National Psoriasis Survey Reveals Its Devastating Impact On ... - Jul 15, 2009 Medical News Today (press release)Newer biological therapies (Enbrel(R), Remicade(R), Amevive(R), Humira(R) and Stelara(TM)) work on the body's immune system, treating psoriasis symptoms Hendricks Regional Health Laboratory earns AABB accreditation - Jul 14, 2009 Indianapolis Star...not-for-profit association dedicated to the advancement of science and the practice of transfusion medicine and related biological therapies. Biopharmaceutical's Strong Lifeline: HGSI, LLBO, CEGE - sourced ... - Jul 16, 2009 TransWorldNews (press release)The company is based in San Francisco and actively develops and commercializes new biological therapies for patients with cancer. PicksThatMove.com is an Using email and text messaging to remind patients to have blood ... - Jul 15, 2009 Nursing TimesThese include azathioprine, mercaptopurine, methotrexate and biological therapies, all of which have seen a marked increase in their use during the last Research and Markets: Special Report - Understanding Treatment ... - Jul 15, 2009 SmartBriefAlthough interviewed thought leaders acknowledge that available biological therapies have greatly improved treatment of juvenile idiopathic arthritis (JIA) Cell Genesys, Inc. Investor Class Action Lawsuit - Jul 17, 2009 PR-CANADA.net (press release)California , is a biotechnology company focused on the development and commercialization of biological therapies for patients with cancer. £6m to spearhead training for a healthcare revolution - 28 Dec 2008 Loughborough News,They believe the next healthcare revolution is in the field of regenerative medicine – creating biological therapies or substitutes for the replacement or Cytomedix Announces Publication of Economic Model Indicating Cost ... - Dec 10, 2008 MarketWatchCytomedix is a biotechnology company that develops, sells, and licenses regenerative biological therapies, including the AutoloGel(tm) System, Cell Genesys Announces Results of its "Modified Dutch Auction ... - Dec 17, 2008 WELT ONLINE,Cell Genesys is a biotechnology company that was focused on the development and commercialization of novel biological therapies for patients with cancer. Cell Genesys Amends and Extends "Modified Dutch Auction�? Tender ... - Dec 2, 2008 WELT ONLINE,Cell Genesys is a biotechnology company that was focused on the development and commercialization of novel biological therapies for patients with cancer. Cellular Senescence A Double-edged Sword - Dec 3, 2008 Science Daily (press release)...“There is a great need for new biological therapies that more effectively exploit the specific differences between normal and cancer cells. Cell Genesys and Takeda Announce Termination of Collaboration ... - Dec 3, 2008 Lifescience-online,Cell Genesys is a biotechnology company that was focused on the development and commercialization of novel biological therapies for patients with cancer. January Is Cervical Health Awareness Month - Dec 12, 2008 Medical News Today (press release),Dr. Nieves-Neira has a long-standing interest in biological therapies, which is directly related to vaccines, specifically the HPV vaccine. Rexahn Pharmaceuticals Strengthens Clinical Development Leadership ... - Nov 17, 2008 Business Wire (press release),She has extensive experience in conducting clinical trials for biological therapies administered in combination cancer regimens, and has served as Principal Biothera to Present Imprime PGG(R) Clinical Trial Results at the ... - Oct 30, 2008 MarketWatch...and clinical data on the use of biological therapies in cancer between basic scientists and clinicians from academic, regulatory and industrial venues. Duke researcher's persistence pays off with new drug for gout - Nov 2, 2008 TMCnetThe child was saved, and the technology of fusing the so-called PEG polymer with biological therapies began to be applied in other long-lasting treatments. Cell Genesys Announces "Modified Dutch Auction" Tender Offer for ... - Nov 7, 2008 WELT ONLINE,Cell Genesys is a biotechnology company that was focused on the development and commercialization of novel biological therapies for patients with cancer. New Cimzia Study Published in Arthritis & Rheumatism Shows Rapid ... - Oct 30, 2008 PharmaLive.com (press release),Anti-TNF (TNF-alpha; Tumor Necrosis Factor) therapies are specific types of biological therapies which have been used in patients with RA. Immune Adjuvants and Cancer Vaccines: Hemispherx's New Enhancement ... - Oct 27, 2008 MarketWatch...of Cancer (iSBTc) is to "facilitate exchange of the most cutting edge preclinical and clinical data on the use of biological therapies in cancer. BUYINS.NET: TIV, ARTC, BCON, BONT, CATY, CEGE Have Also Been ... - Oct 23, 2008 Trading Markets (press release),Chart | News | PowerRating) a biotechnology company, engages in the development and commercialization of biological therapies for patients with cancer. New data supports case for funding MabThera®( - Nov 9, 2008 Scoop.co.nz (press release),...have failed other treatments, MabThera is a well tolerated, effective2 and is a cost-effective treatment5, when compared to other biological therapies. CIMZIA(R) (Certolizumab Pegol) Provides Rapid And Sustained Relief ... - Oct 28, 2008 Medical News Today (press release),Anti-TNF (TNF-alpha; Tumor Necrosis Factor) therapies are specific types of biological therapies which have been used in patients with RA. Anti-Tumour Necrosis Factors Are Not Associated With Increased ... - Oct 30, 2008 DG News...a Spanish registry established in 2001 for long-term monitoring of the safety of biological therapies used to treat rheumatological diseases. Rodman & Renshaw Annual Global Investment Conference Presenter ... - Nov 7, 2008 Centre Daily Times,12, 2008 (2:25 pm) Cytomedix is a biotechnology company that develops, sells, and licenses regenerative biological therapies, including the AutoloGel(TM) Biologics Don't Raise Cancer Risk in Rheumatoid Arthritis Patients - Oct 28, 2008 Forbes,The data in this new study came from a drug registry called BIOBADASER, established in 2001 for long-term follow up of the safety of biological therapies in ACR: Novel Oral Agent Improves Rheumatoid Arthritis Symptoms - Oct 28, 2008 MedPage Today,..."It's encouraging for rheumatologists that, in addition to biological therapies that have been demonstrated to be effective," he said, "we are looking at a University of Nottingham and Lipoxen plc join forces to fight ... - Nov 5, 2008 Media Newswire (press release),Lipoxen plc, a bio-pharmaceutical company specialising in the development of high-value biological therapies including vaccines and oncology drugs, New Study Highlights Need for Better Interaction and Education ... - Oct 28, 2008 PR Newswire (press release),Anti-TNF (TNF-alpha; Tumor Necrosis Factor) therapies are specific types of biological therapies which have been used in patients with RA. Rodman & Renshaw Annual Global Investment Conference Presenter ... - Nov 7, 2008 TMC Net,12, 2008 (2:25 pm) Cytomedix is a biotechnology company that develops, sells, and licenses regenerative biological therapies, including the AutoloGel(TM) Focus on...the drug access lottery - Nov 12, 2008 Pulse,NICE approved use of the biological therapies etanercept and infliximab for rheumatoid arthritis that had not responded adequately to at least two Background information on Biological Therapies [When available] Biological therapy is a type of treatment that works with your immune system. It can help fight cancer or help control side effects (how your body reacts to the drugs you are taking) from other cancer treatments like chemotherapy. What is the difference between biological therapy and chemotherapy? Biological therapy and chemotherapy are both treatments that fight cancer. While they may seem alike, they work in different ways. Biological therapy helps your immune system fight cancer. Chemotherapy attacks the cancer cells directly. How does biological therapy fight cancer? Doctors are not sure how biological therapy helps your immune system fight cancer. But they think it may:
Search the web for more resources on Biological Therapies |
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |